LORBRENA (lorlatinib) tablets is used for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC)

LORBRENA is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on  crizotinib and at least one other ALK inhibitor for metastatic disease; or  alectinib as the first ALK inhibitor therapy for metastatic disease; or  ceritinib as the first ALK inhibitor therapy for metastatic disease.

LORBRENA (lorlatinib) tablets suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of LORBRENA (lorlatinib) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the LORBRENA (lorlatinib) tablets medicine cost price in India.

The order for LORBRENA (lorlatinib) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Lorlatinib is approved in the US and in Europe for the second- or third-line treatment of ALK-positive metastatic non-small-cell lung cancer (NSCLC).

LORBRENA (lorlatinib) tablets, for intravenous use Initial U.S. Approval: 2017

Generic Name: lorlatinib

Lorbrena (Lorlatinib)

LORBRENA (lorlatinib) tablets is available.

Get In Touch

LORBRENA (lorlatinib) tablets suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand LORBRENA (lorlatinib) tablets on prescription and Import License in Patient's Name only.

For overseas patients, LORBRENA (lorlatinib) tablets can be made available in Send your enquiry to find LORBRENA (lorlatinib) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for LORBRENA (lorlatinib) tablets.

For LORBRENA (lorlatinib) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

U.S. FDA Approves LORBRENA® (lorlatinib) for Previously-Treated ALK-Positive Metastatic NSCLC For More Details

Pfizer claims rapid FDA nod for Lorbrena For More Details

Channel Partner In India

Delhi Office

60/4, T&T House. Yusuf Sarai,
New Delhi:110016

Bangalore Office

#308, Raheja Chambers, 12,
Museum Road, Bangalore 560 001

Kolkata Office

1/A R.G Kar Road, Shayambazar,
Kolkata 700004

Lucknow Office

203-A, 2nd Floor, Tower -11, Felix
Square, IBB-2, Sushant Golf city, Lucknow 226030